RFC2 and cancer: Furthermore, as the DNA single-strand break repair pathway is essential for cell survival as an alternative pathway in cancer cells with BRCA mutations, inhibition of the NER pathway by RFC2 in addition to PARPi may have additional therapeutic efficacy for CRPC treatment.